Women with bipolar disorder are more likely to experience depressive states, rapid cycling, and co-occuring conditions like alcoholism and anxiety.

An antipsychotic approved by the FDA in 2009 to treat schizophrenia has now been green-lighted for use in bipolar 1 disorder. Iloperidone (Fanapt) is now FDA-approved for adults with bipolar 1 ...

Bipolar disorders present a high rate of misdiagnosis issues (e.g., Rakofsky et al., 2015; Shen et al., 2018; McIntyre et al., 2022). This has a lot to do with poor differential diagnosis practice and ...

Schizoaffective bipolar disorder is a rare mental health condition that displays characteristics of bipolar disorder and ...

Long-term mood stabilizer use in bipolar disorder Mixed and psychotic features and comorbid anxiety disorder were also associated with poor treatment response. About one-third of patients receiving ...

FRESNO, Calif. (KFSN) -- A Fresno State student is taking action to shed light on a topic that's often tough to discuss: mental health. It started as a senior project for Fresno State business student ...

Over the past three weeks, we've lifted the masks of many Major Depressive Disorder (MDD) presentation variations. Today, we'll investigate Mixed Features before moving onto specifiers of onset.

Migraine pain can intensify depression, anxiety, and mood symptoms in bipolar disorder. The good news is that some treatments ...

Vanda Pharmaceuticals announces the FDA approval of iloperidone (Fanapt) for the acute treatment of bipolar 1 disorder. Iloperidone is a second-generation atypical antipsychotic agent for managing ...